Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-24-001823
Filing Date
2024-01-22
Accepted
2024-01-22 10:24:35
Documents
16
Period of Report
2024-01-22

Document Format Files

Seq Description Document Type Size
1 6-K a240122_6kxmorxvotingright.htm 6-K 11511
2 EX-99.1 exhibit_991.htm EX-99.1 5146
3 EX-99.2 exhibit_992.htm EX-99.2 5350
4 EX-99.3 exhibit_993.htm EX-99.3 6903
5 GRAPHIC exhibit_991001.jpg GRAPHIC 124701
6 GRAPHIC exhibit_991002.jpg GRAPHIC 138964
7 GRAPHIC exhibit_991003.jpg GRAPHIC 96609
8 GRAPHIC exhibit_992001.jpg GRAPHIC 126192
9 GRAPHIC exhibit_992002.jpg GRAPHIC 139116
10 GRAPHIC exhibit_992003.jpg GRAPHIC 104796
11 GRAPHIC exhibit_993001.jpg GRAPHIC 116165
12 GRAPHIC exhibit_993002.jpg GRAPHIC 131638
13 GRAPHIC exhibit_993003.jpg GRAPHIC 125341
14 GRAPHIC exhibit_993004.jpg GRAPHIC 91177
15 GRAPHIC exhibit_993005.jpg GRAPHIC 102371
16 GRAPHIC exhibit_993006.jpg GRAPHIC 56868
  Complete submission text file 0001628280-24-001823.txt   1895488
Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Filer) CIK: 0001340243 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38455 | Film No.: 24547379
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)